Crona CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Crona Corp.'s 10-K filing reveals a net loss of $77,395 for 2024, alongside a shift in business focus to the memorialization industry.
OTC.Pink
Crona Corp. transitioned from antimicrobial surface protection to the memorialization industry, experiencing a net loss of $193,626 in 2023, and a change in management.